IBDEI14L ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18073,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,18074,0)
 ;;=E10.69^^88^908^29
 ;;^UTILITY(U,$J,358.3,18074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18074,1,3,0)
 ;;=3^DM Type 1 w/ Oth Spec Compl
 ;;^UTILITY(U,$J,358.3,18074,1,4,0)
 ;;=4^E10.69
 ;;^UTILITY(U,$J,358.3,18074,2)
 ;;=^5002624
 ;;^UTILITY(U,$J,358.3,18075,0)
 ;;=E10.8^^88^908^33
 ;;^UTILITY(U,$J,358.3,18075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18075,1,3,0)
 ;;=3^DM Type 1 w/ Unspec Compl
 ;;^UTILITY(U,$J,358.3,18075,1,4,0)
 ;;=4^E10.8
 ;;^UTILITY(U,$J,358.3,18075,2)
 ;;=^5002625
 ;;^UTILITY(U,$J,358.3,18076,0)
 ;;=E10.9^^88^908^34
 ;;^UTILITY(U,$J,358.3,18076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18076,1,3,0)
 ;;=3^DM Type 1 w/o Compl
 ;;^UTILITY(U,$J,358.3,18076,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,18076,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,18077,0)
 ;;=E10.620^^88^908^5
 ;;^UTILITY(U,$J,358.3,18077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18077,1,3,0)
 ;;=3^DM Type 1 w/ Diab Dermatitis
 ;;^UTILITY(U,$J,358.3,18077,1,4,0)
 ;;=4^E10.620
 ;;^UTILITY(U,$J,358.3,18077,2)
 ;;=^5002615
 ;;^UTILITY(U,$J,358.3,18078,0)
 ;;=E10.36^^88^908^4
 ;;^UTILITY(U,$J,358.3,18078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18078,1,3,0)
 ;;=3^DM Type 1 w/ Diab Cataract
 ;;^UTILITY(U,$J,358.3,18078,1,4,0)
 ;;=4^E10.36
 ;;^UTILITY(U,$J,358.3,18078,2)
 ;;=^5002602
 ;;^UTILITY(U,$J,358.3,18079,0)
 ;;=E10.621^^88^908^6
 ;;^UTILITY(U,$J,358.3,18079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18079,1,3,0)
 ;;=3^DM Type 1 w/ Diab Foot Ulcer
 ;;^UTILITY(U,$J,358.3,18079,1,4,0)
 ;;=4^E10.621
 ;;^UTILITY(U,$J,358.3,18079,2)
 ;;=^5002616
 ;;^UTILITY(U,$J,358.3,18080,0)
 ;;=E10.622^^88^908^28
 ;;^UTILITY(U,$J,358.3,18080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18080,1,3,0)
 ;;=3^DM Type 1 w/ Oth Skin Ulcer
 ;;^UTILITY(U,$J,358.3,18080,1,4,0)
 ;;=4^E10.622
 ;;^UTILITY(U,$J,358.3,18080,2)
 ;;=^5002617
 ;;^UTILITY(U,$J,358.3,18081,0)
 ;;=E10.51^^88^908^32
 ;;^UTILITY(U,$J,358.3,18081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18081,1,3,0)
 ;;=3^DM Type 1 w/ Periph Angiopathy w/o Gangrene
 ;;^UTILITY(U,$J,358.3,18081,1,4,0)
 ;;=4^E10.51
 ;;^UTILITY(U,$J,358.3,18081,2)
 ;;=^5002610
 ;;^UTILITY(U,$J,358.3,18082,0)
 ;;=E10.52^^88^908^31
 ;;^UTILITY(U,$J,358.3,18082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18082,1,3,0)
 ;;=3^DM Type 1 w/ Periph Angiopathy w/ Gangrene
 ;;^UTILITY(U,$J,358.3,18082,1,4,0)
 ;;=4^E10.52
 ;;^UTILITY(U,$J,358.3,18082,2)
 ;;=^5002611
 ;;^UTILITY(U,$J,358.3,18083,0)
 ;;=E11.00^^88^909^19
 ;;^UTILITY(U,$J,358.3,18083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18083,1,3,0)
 ;;=3^DM Type 2 w/ Hyperosmolarity w/o NKHHC
 ;;^UTILITY(U,$J,358.3,18083,1,4,0)
 ;;=4^E11.00
 ;;^UTILITY(U,$J,358.3,18083,2)
 ;;=^5002627
 ;;^UTILITY(U,$J,358.3,18084,0)
 ;;=E11.01^^88^909^18
 ;;^UTILITY(U,$J,358.3,18084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18084,1,3,0)
 ;;=3^DM Type 2 w/ Hyperosmolarity w/ Coma
 ;;^UTILITY(U,$J,358.3,18084,1,4,0)
 ;;=4^E11.01
 ;;^UTILITY(U,$J,358.3,18084,2)
 ;;=^5002628
 ;;^UTILITY(U,$J,358.3,18085,0)
 ;;=E11.21^^88^909^7
 ;;^UTILITY(U,$J,358.3,18085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18085,1,3,0)
 ;;=3^DM Type 2 w/ Diab Nephropathy
 ;;^UTILITY(U,$J,358.3,18085,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,18085,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,18086,0)
 ;;=E11.22^^88^909^3
